智通财经APP讯，普华和顺(01358)公布四川睿健医疗2025年第一季度业绩，收入约1.45亿元，同比增长43.89%。归属于四川睿健医疗股东的净利润约3617.11万元，同比增长15.68%。
公告称，收入较去年同期增长43.89%，主要归功于四川睿健医疗持续致力拓展国内外市场，产品品牌知名度逐步提升，市场竞争力增强，加上需求不断增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.